San Francisco Biotech →
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Director, Life Sciences Institute, University of Michigan
Partner, Third Rock Ventures
Founder and Managing Director of DEV
Founding Director, Massachusetts Technology Transfer Center
CEO of Project Foundry
CEO of Dynamis Corporation
Professor of Systems Biology, Columbia University
November 4, 2018 · Boston
December 5, 2018 · San Francisco
December 18, 2018 · New York
Matthew Scholz is the CEO of Immusoft, a (currently) Seattle based biotech startup that is commercializing technology to program the human immune system.
If Seattle is to occupy a future place of dominance in the biotech world, it must foster more of an “incubator” culture. There is a “valley of death” between the well-funded... Read more »
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Robust ecosystem supports tech hub and startup community
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2018, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.